Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Angiogenesis - SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
Arthroscopy - Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: the Journal of Arthroscopic and Related Surgery
AVEO Pharmaceuticals, Inc. - AVEO Initiates Phase 1b Combination Trial of AV-951 with FOLFOX6 in Patients with Advanced Colorectal and Other Gastrointestinal Cancers
Biotech Business - MDS Pharma Services Strengthens Medical Leadership in Phase IIa Clinical Research
Bird Flu - Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Cell Genesys, Inc. - Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
Celsion Corporation - ThermoDox Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008
Clinical Research - After Their U.S. Purchase, Algorithme Pharma Gains a Foothold in Europe Through the Acquisition of a New Clinical Research Location in the United Kingdom
Clinical Trial Research - Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
Clinical Trial Research - Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
Curis, Inc. - Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors
Diabetic Retinopathy - NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration With Pfizer
Flu Vaccines - VaxInnates M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
Memory Pharmaceuticals Corp. - Memory Pharmaceuticals Closes Final Tranche of Equity Financing with the Stanley Medical Research Institute
Morphotek, Inc. - Morphotek, Inc. Expands Its Phase II Trial Site Selections in the European Union
Neurodegenerative Disease - Eric Karran, CSO of the Neurodegenerative Diseases Drug Hunting Team at Eli Lilly & Co. to Give Keynote Presentation at GTCbios 4th Neurodegenerative Diseases Drug Discovery Conference in Philadelphia, PA
Oxygen Biotherapeutics, Inc. - Oxygen Biotherapeutics, Inc. to Meet With FDA to Discuss Proposed Phase II-b Oxycyte Clinical Trial
Pfizer Inc - Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program
Pharmos Corporation - Pharmos Corporation Announces That it Will Cease Operations in Israel
Pneumonia - Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbios Bugs & Drugs Conference in San Diego, CA
The Multiple Myeloma Research Consortium - The Multiple Myeloma Research Consortium MMRC Partners with Celgene Corporation on Phase I/II Trial of Pomalidomide CC-4047 in Relapsed and Refractory Multiple Myeloma Patients
Vaccines - Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection